封面
市场调查报告书
商品编码
1984176

NGS资讯学市场:2026-2032年全球市场预测(按组件、技术、部署模式、工作流程类型、应用和最终用户划分)

NGS Informatics Market by Component, Technology, Deployment Mode, Workflow Type, Application, End User - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年,NGS 资讯学市场价值将达到 410.2 亿美元,到 2026 年将成长至 488.6 亿美元,年复合成长率为 22.08%,到 2032 年将达到 1,658.3 亿美元。

主要市场统计数据
基准年 2025 410.2亿美元
预计年份:2026年 488.6亿美元
预测年份 2032 1658.3亿美元
复合年增长率 (%) 22.08%

简要概述为什么次世代定序资讯学现在是研究、诊断和生物技术组织策略运作的基础。

次世代定序资讯学目前正处于三大因素的交会点:科技的快速创新、临床领域的广泛应用以及日益严格的监管。随着定序处理能力的不断提升及其应用范围从基础研究扩展到临床诊断,资讯学已从单纯的辅助功能演变为一项策略差异化因素。本文概述了决策者在将资讯学投资与组织目标相契合时必须面对的核心功能、新挑战和实际操作问题。

计算技术的进步、云端运算的成熟、监管的加强以及劳动力的转型是如何相互交织,从而重新定义 NGS 资讯学的价值炼和竞争格局的?

在技​​术、监管和商业性因素的共同推动下,新一代定序(NGS)资讯学领域正经历着一场变革。包括机器学习和基于图的方法在内的演算法方法的进步,显着提高了变异检测、註释准确性和解读能力,从而能够对复杂的基因组讯号进行更深入的解读。同时,长读长定定序和单细胞定序技术正在拓展资讯学必须应对的生物学挑战范围,这要求建构能够处理更高维度和更丰富元元资料的架构。

一项基于证据的审查,旨在探讨 2025 年关税将如何改变供应链策略、采购模式以及定序和资讯学领域所有相关人员的营运规划。

美国将于2025年实施关税,这为依赖进口硬体、试剂和专用资讯设备的机构的采购和营运规划带来了结构性复杂性。虽然关税主要针对有形资产,但其连锁反应会波及软体驱动的工作流程,增加边缘运算、定序设备和託管基础设施部署相关的资本和营运成本。因此,采购团队现在更加严格地评估总体拥有成本 (TCO),并将不断上涨的进口关税、波动的运输成本以及海关延误等因素考虑在内。

细分领域的洞察揭示了应用程式需求、元件角色、最终用户需求、技术选择、部署偏好和工作流程阶段如何共同决定资讯科学的优先事项。

要精准了解市场,需要基于细分市场的洞察,这些洞察应反映出各个应用的具体需求、组件角色、最终用户需求、技术层级、部署偏好和工作流程阶段。应用主导的需求在癌症研究、遗传疾病研究、感染疾病研究和生殖健康项目等领域各不相同。即使在癌症研究领域,由于突变谱分析和临床解读需求的差异,分析也必须区分血液系统恶性肿瘤(造血系统癌症)和固态肿瘤。感染疾病应用也呈现其独特的差异。细菌基因组学工作流程优先考虑基因组组装和抗生素抗药性检测,而病毒基因组学则强调快速建立共识序列和系统发育分析。生殖医学应用涵盖从亲子鑑定到产前筛检的各个方面,每项应用都需要特定的灵敏度和报告标准。

美洲、欧洲、中东和非洲以及亚太地区的区域法规结构、基础设施成熟度和投资模式如何塑造 NGS 资讯学的采用和采购的独特路径。

区域趋势对资讯学应用模式、监管立场和投资重点有显着影响,美洲、欧洲、中东和非洲(EMEA)以及亚太地区呈现不同的特征。在美洲,强劲的私营部门投资、成熟的云端生态系以及紧密的参考检查室网路正在推动先进资讯学平台的快速普及。然而,不同司法管辖区的监管差异以及近期的关税环境使得谨慎选择供应商和对冲供应链风险变得至关重要。此外,美洲正在建构一个充满活力的产学研转化平台,以支持实验性资讯学方法与商业平台的早期应用。

供应商的策略行动、伙伴关係模式和能力组合定义了序列资讯学生态系统中的竞争结构和买方决策标准。

生物资讯学领域的竞争格局由众多参与者构成,包括成熟的企业软体供应商、专业的生物资讯工具供应商、云端超大规模资料中心业者服务商、正在拓展软体生态系统的定序平台製造商,以及专注于小众、高价值应用场景的敏捷型Start-Ups。成熟的供应商提供整合套件、检验支援和企业级服务等级协定 (SLA),因此对重视合规性和供应商课责的医院和大型製药企业极具吸引力。同时,专业的工具提供者和Start-Ups往往在分析方法、视觉化和使用者体验方面创新速度更快,通常致力于解决结构突变识别、单细胞数据分析或互动式队列探索等特定挑战。

为了确保长期的竞争优势,营运经理和主管现在可以采取具体措施,以建立具有弹性的供应链、可扩展的资讯架构和人才能力。

寻求竞争优势的领导者应优先采取一系列切实可行的措施来应对短期营运风险,同时确保能力建设投资与业务目标保持一致。首先,应实现供应链多元化,并协商制定足够灵活的采购合同,以应对关税波动和交货中可能出现的意外情况。此外,在适当情况下,应考虑采用租赁或订阅模式采购资本设备,以减轻前期成本负担。其次,应投资于混合云端架构和容器化、工作流程定义的管道,以提高可携性、可复现性和成本控制,同时确保建立资料管治框架,以管理跨境资料流和合规义务。

我们采用了一种综合性的混合方法,结合文献整合、相关人员访谈、专家检验和迭代品管,以确保研究结果基于证据。

本分析的调查方法结合了多方面的证据、专家咨询和结构化检验,以确保得出可靠且可操作的见解。该方法首先对技术文献、供应商文件、监管指南和同行评审的研究进行了全面审查,以了解当前的技术能力和调查方法趋势。此外,还对包括生物资讯学家、实验室经理、采购经理、供应商高阶主管和临床终端使用者在内的各类相关人员进行了一系列深入访谈,以了解实际营运和策略意图。

策略整合凸显了模组化架构、人才投资和强大的采购系统对于释放 NGS 资讯学的全部潜力至关重要。

总之,次世代定序的资讯层已从营运成本转变为影响科学成果、临床路径和商业性竞争的策略资产。诸如演算法改进、云端原生架构和更丰富的定序方法等技术进步拓展了应用前景,但也增加了管治、检验和人才需求的复杂性。关税的引入和不断变化的区域环境进一步加剧了采购和部署决策的复杂性,凸显了灵活采购模式和稳健情境规划的必要性。

目录

第一章:序言

第二章:调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵,2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章:美国关税的累积影响,2025年

第七章:人工智慧的累积影响,2025年

第八章 NGS资讯学市场:按组件划分

  • 服务
    • 客户服务
    • 订阅服务
  • 软体工具
    • 资料管理工具
    • 序列资料分析工具
    • 视觉化工具

第九章 NGS资讯学市场:依技术划分

  • 数据分析
    • 比对和映射
    • 註记与解释
    • 变体调用
  • 资料管理
    • 电子资料撷取系统
    • 检查资讯管理系统
  • 资料网关
    • 云端储存
    • 本地储存

第十章:NGS资讯学市场:依部署模式划分

    • 私有云端
    • 公共云端
  • 现场

第十一章 依工作流程类型分類的NGS资讯学市场

  • 初步分析
    • 基地识别
    • 影像处理
  • 二次分析
    • 结盟
    • 品管
    • 变体调用
  • 三级分析
    • 资料探勘
    • 报告创建和可视化

第十二章 NGS 资讯学市场:按应用划分

  • 癌症调查
    • 血癌
    • 固体癌
  • 遗传疾病调查
  • 感染疾病
    • 细菌基因体学
    • 病毒基因组学
  • 生殖医学
    • 亲子鑑定
    • 产前筛检

第十三章 NGS 资讯学市场:依最终使用者划分

  • 学术研究机构
    • 私人研究机构
    • 公立大学
  • 合约研究机构
  • 医疗保健提供者
    • 诊断检测实验室
    • 医院
  • 製药和生物技术公司
    • 大型製药企业
    • 中小型生技公司

第十四章 NGS 资讯学市场:按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 NGS 资讯学市场:依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 NGS 资讯学市场:按国家/地区划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章:美国NGS资讯学市场

第十八章:中国NGS资讯市场

第十九章 竞争情势

  • 市场集中度分析,2025年
    • 浓度比(CR)
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析,2025 年
  • 2025年产品系列分析
  • 基准分析,2025 年
  • Agilent Technologies Inc.
  • Azenta Life Sciences
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Dassault Systemes
  • Dnanexus Inc.
  • DNASTAR Inc.
  • Eagle Genomics Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Fabric Genomics Inc.
  • Genedata AG
  • IBM Corporation
  • Illumina, Inc.
  • Partek Incorporated
  • PerkinElmer, Inc
  • PerkinElmer, Inc.
  • PierianDx, Inc.
  • Qiagen NV
  • Real Time Genomics Inc.
  • Roche Diagnostics International AG
  • Sapio Sciences
  • SoftGenetics, LLC
  • Thermo Fischer Scientific Inc.
Product Code: MRR-5C6F41F5AFE9

The NGS Informatics Market was valued at USD 41.02 billion in 2025 and is projected to grow to USD 48.86 billion in 2026, with a CAGR of 22.08%, reaching USD 165.83 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 41.02 billion
Estimated Year [2026] USD 48.86 billion
Forecast Year [2032] USD 165.83 billion
CAGR (%) 22.08%

A concise orientation to why next-generation sequencing informatics now acts as a strategic operational backbone for research, diagnostics, and biotechnology organizations

Next-generation sequencing informatics now sits at the intersection of rapid technological innovation, expanding clinical adoption, and intensifying regulatory scrutiny. As sequencing throughput continues to increase and the diversity of applications broadens from basic research to clinical diagnostics, informatics has evolved from a supporting capability into a strategic differentiator. This introduction outlines the core functions, emergent pressures, and the operational realities that decision-makers must confront when aligning informatics investments with organizational objectives.

Across research institutions, clinical laboratories, and biotech firms, informatics pipelines are no longer optional back-end utilities; they are mission-critical systems that must deliver traceable, reproducible, and interpretable results at scale. The operational demands include processing ever-larger volumes of raw reads, integrating multi-omic datasets, and ensuring secure, compliant storage and access. In parallel, stakeholders face challenges related to skills shortages, heterogeneous data formats, and varying levels of cloud readiness. These constraints shape procurement, vendor selection, and internal capability-building.

This introductory overview frames subsequent sections by distilling why informatics investments matter now: they affect time-to-insight for research programs, the accuracy and reproducibility of clinical reports, and the cost structure of sequencing operations. By establishing this baseline, the reader can better appreciate the strategic trade-offs between custom-built pipelines and commercial platforms, the importance of modularity and interoperability, and the need for robust governance frameworks that span data management, security, and regulatory compliance.

How computational advances, cloud maturity, regulatory scrutiny, and workforce evolution are converging to redefine the NGS informatics value chain and competitive dynamics

The landscape of NGS informatics is undergoing transformative shifts driven by converging technological, regulatory, and commercial forces. Advances in algorithmic approaches, including machine learning and graph-based methods, have materially improved variant detection, annotation accuracy, and interpretive throughput, enabling more nuanced interpretation of complex genomic signals. Concurrently, long-read sequencing and single-cell approaches are expanding the types of biological questions that informatics must support, prompting architectures that can handle higher dimensionality and richer metadata.

Cloud adoption has matured from experimental pilots to production deployments, changing the economics of compute and storage while elevating concerns around data sovereignty, latency, and cost predictability. Standardization efforts are gaining momentum, with the community increasingly focusing on exchange formats, APIs, and reproducible workflow specifications to reduce friction across platforms and institutions. This drive toward interoperability is complemented by a marketplace shift: open-source toolchains coexist with commercial platforms, and hybrid models that combine managed services with extensible software suites are becoming the norm.

At the same time, regulatory and payer attention on clinical sequencing has increased, leading to greater emphasis on validation, auditability, and explainability of analytic pipelines. These pressures encourage investments in provenance tracking, version control, and certified workflows. Finally, talent dynamics are changing; the demand for bioinformaticians with cloud engineering, data science, and software development skills is increasing, incentivizing investments in training and collaborative partnerships. Collectively, these shifts are reshaping procurement decisions, partnership strategies, and internal capability roadmaps across the sector.

An evidence-based review of how the 2025 tariffs have reshaped supply chain strategies, procurement models, and operational planning across sequencing informatics stakeholders

The imposition of tariffs in the United States in 2025 has introduced a layer of structural complexity to procurement and operational planning for organizations that depend on imported hardware, reagents, and specialized informatics appliances. Although tariffs primarily target tangible goods, the downstream effects permeate software-enabled workflows by increasing the capital and operational costs associated with deploying edge compute, sequencing instruments, and co-located infrastructure. Procurement teams are consequently evaluating total cost of ownership more rigorously, accounting for elevated import duties, shipping variability, and customs-related delays.

One immediate consequence is a reorientation toward localized sourcing strategies and strategic inventory buffering to mitigate supply disruptions. Laboratories and service providers have begun reassessing supplier portfolios, prioritizing partners with resilient manufacturing footprints or regional distribution hubs that minimize tariff exposure. For vendors, tariffs have accelerated conversations about regional assembly, device redesign to use components sourced from lower-tariff jurisdictions, and revisiting pricing models to absorb or pass through new costs.

The cumulative impact extends to collaborations and contract structures. Contract research organizations and academic consortia are renegotiating terms to include tariff risk-sharing clauses, adjusting timelines for capital-intensive projects, and exploring lease or subscription models for equipment to dampen upfront tariff-driven expense shocks. Additionally, tariff-driven cost pressures are prompting some stakeholders to prioritize software-centric optimizations-improving data compression, computational efficiency, and cloud-native practices-to offset higher hardware-related costs. Taken together, these developments are forcing a re-evaluation of supply chain resilience, procurement policy, and long-term investment priorities across the NGS informatics ecosystem.

Segment-level intelligence revealing how application needs, component roles, end-user requirements, technology choices, deployment preferences, and workflow stages collectively determine informatics priorities

A nuanced understanding of the market requires segmentation-based insight that reflects distinct application needs, component roles, end-user demands, technological layers, deployment preferences, and workflow stages. Application-driven requirements vary across cancer research, genetic disorder research, infectious disease work, and reproductive health programs, and within cancer research the analytics must distinguish between hematologic cancers and solid tumors because of differing variant profiles and clinical interpretation needs. Infectious disease applications present their own bifurcation: bacterial genomics workflows prioritize assembly and antimicrobial resistance detection while viral genomics focus on rapid consensus generation and phylogenetics; reproductive health applications span paternity testing and prenatal screening, each demanding specific sensitivity and reporting conventions.

Component segmentation highlights the divergence between services and software tools. Services encompass custom offerings tailored to specific study designs and subscription services that provide continuous support and updates, whereas software tools include data management platforms, sequencing data analysis suites, and visualization instruments which together form the operational backbone for data ingestion, processing, and interpretation. End users display differentiated buying behaviors and capability expectations: academic and research institutions, including private research institutes and public universities, often prioritize flexibility and methodological transparency; contract research organizations, split across clinical and preclinical CROs, emphasize throughput and validated workflows; healthcare providers, from diagnostic laboratories to hospitals, require compliance, turn-key integration, and reproducible clinical reporting; and pharmaceutical and biotechnology companies, whether large pharma or small biotech, combine requirements for security, scalability, and regulatory-grade validation.

Technology-level segmentation further clarifies buyer priorities by distinguishing data analysis, which includes alignment, annotation, and variant calling subfunctions, from data management solutions such as electronic data capture and laboratory information management systems, and data storage choices between cloud and on-premise modalities. Deployment mode choices pivot on cloud or on-premise architectures, with cloud options subdivided into private and public clouds and on-premise solutions ranging from co-located data centers to in-house installations, each presenting distinct trade-offs in cost, control, latency, and compliance. Finally, workflow segmentation across primary, secondary, and tertiary analysis stages underscores the operational sequence from base calling and image processing to alignment, quality control, variant calling, and onwards to data mining and reporting. Integrating these segment perspectives reveals where value accrues, where integration challenges persist, and which combinations of offerings best meet the requirements of different stakeholder cohorts.

How regional regulatory frameworks, infrastructure maturity, and investment patterns in the Americas, EMEA, and Asia-Pacific shape distinct pathways for NGS informatics adoption and procurement

Regional dynamics exert a strong influence on informatics adoption patterns, regulatory posture, and investment priorities, with distinct profiles emerging across the Americas, Europe Middle East and Africa, and Asia-Pacific regions. In the Americas, strong private-sector investment, a mature cloud ecosystem, and a dense network of reference laboratories facilitate rapid adoption of advanced informatics platforms, though regulatory variability between jurisdictions and the recent tariff environment prompt careful vendor selection and supply chain hedging. The Americas also feature active translational pipelines between academic centers and industry, supporting early adoption of experimental informatics methods alongside commercial platforms.

In Europe, the Middle East and Africa, regulatory harmonization efforts, and robust public health initiatives shape demand, with many organizations prioritizing data sovereignty, stringent privacy compliance, and hybrid deployment architectures. Interoperability and standardization are prominent themes, as pan-regional health initiatives incentivize shared formats and APIs. In the Middle East and Africa specifically, infrastructure gaps and uneven access to skilled bioinformatics personnel create opportunities for managed services and training partnerships that bridge capability shortfalls.

The Asia-Pacific region is characterized by a rapidly expanding base of sequencing facilities, growing domestic manufacturing capabilities, and aggressive public and private R&D investments. Cloud adoption varies across markets, but where it is mature, it supports high-throughput sequencing programs and large-scale population genomics initiatives. Across all regions, local regulatory frameworks, reimbursement policies, and talent availability will continue to shape procurement decisions and the relative appeal of cloud-native versus on-premise solutions, emphasizing the need for region-specific go-to-market strategies and partnership models.

Strategic vendor behaviors, partnership models, and capability portfolios that define the competitive contours of the sequencing informatics ecosystem and buyer decision criteria

The competitive landscape in informatics is defined by a spectrum of players that include established enterprise software vendors, specialist bioinformatics tool providers, cloud hyperscalers, sequencing platform manufacturers extending into software ecosystems, and nimble start-ups focused on narrow, high-value use cases. Established vendors bring integrated suites, validation support, and enterprise-grade SLAs, making them attractive to hospitals and large pharmaceutical companies that prioritize compliance and vendor accountability. Specialist tool providers and start-ups tend to innovate faster in analytics methods, visualization, and user experience, often addressing specific pain points such as structural variant calling, single-cell interpretation, or interactive cohort exploration.

Cloud providers play a dual role: they supply scalable compute and storage and increasingly offer managed genomics services that package best-practice workflows, security controls, and billing models. This has shifted vendor engagement models, enabling partnerships where platform vendors embed cloud-native services while retaining the option for hybrid or on-premise deployments. Meanwhile, service-oriented organizations-including CROs and managed service providers-differentiate through domain expertise, throughput guarantees, and regulatory compliance support, often serving as the bridge for institutions that lack in-house informatics capabilities.

Across the ecosystem, strategic behaviors such as vertical integration, partnership ecosystems, and M&A are evident. Companies that combine strong algorithmic IP with robust deployment and validation capabilities command attention from enterprise buyers. Open-source projects remain a vital source of innovation and community validation, and vendors that balance openness with enterprise support often enjoy broader adoption. For buyers, vendor evaluation should emphasize roadmap transparency, support for standards, interoperability, and demonstrable validation across relevant use cases.

Actionable steps that operational leaders and executives can implement now to build resilient supply chains, scalable informatics architectures, and workforce capabilities for long-term advantage

Leaders seeking to secure a competitive advantage should prioritize a set of pragmatic actions that align capability investments with business objectives while addressing near-term operational risks. First, diversify the supply chain and negotiate procurement contracts that include flexibility for tariff fluctuations and delivery contingencies; consider lease or subscription models for capital equipment where appropriate to reduce upfront exposure. Second, invest in hybrid cloud architectures and containerized, workflow-defined pipelines to improve portability, reproducibility, and cost control, while ensuring that data governance frameworks are in place to manage cross-border flows and compliance obligations.

Third, accelerate workforce development by combining targeted hiring with internal training programs that blend bioinformatics, cloud engineering, and software development skills; partnerships with academic institutions and targeted internships can help build a steady talent pipeline. Fourth, adopt standards-based APIs and provenance-tracking mechanisms to facilitate interoperability, reduce vendor lock-in, and simplify regulatory validation. Fifth, engage in strategic partnerships and alliances that augment internal capabilities-collaborations with CROs, specialist analytics vendors, and managed service providers can deliver immediate capacity and validated workflows.

Finally, incorporate tariff and geopolitical risk into scenario planning and R&D prioritization, and maintain an active dialogue with policymakers to communicate the downstream impacts of trade policies on research and clinical services. By pursuing these actions, organizations can reduce operational fragility, accelerate time-to-insight, and create a more defensible position in an increasingly competitive and regulated environment.

A comprehensive mixed-methods research approach combining literature synthesis, stakeholder interviews, expert validation, and iterative quality controls to ensure evidence-based insights

The research methodology underpinning this analysis combined multi-source evidence, expert consultation, and structured validation to ensure robust, actionable findings. The approach began with a comprehensive review of technical literature, vendor documentation, regulatory guidance, and peer-reviewed studies to map current technological capabilities and methodological trends. This secondary analysis was complemented by a series of in-depth interviews with a diverse set of stakeholders, including bioinformaticians, laboratory directors, procurement leads, vendor executives, and clinical end users, to capture operational realities and strategic intent.

Quantitative and qualitative data were synthesized to create segmentation frameworks that align application needs, technology choices, deployment preferences, and workflow stages. Validation workshops with domain experts were conducted to stress-test assumptions, refine taxonomy definitions, and ensure that regional nuances were accurately reflected. Quality controls included cross-referencing primary interview claims against published protocols and vendor technical specifications, anonymized triangulation of reported behaviors, and iterative review cycles to resolve discrepancies.

The methodology emphasized transparency and traceability: all key assertions are supported by documented sources or attributed expert input, and limitations are acknowledged where data gaps exist. Where necessary, conservative judgement was applied to reconcile conflicting inputs, and sensitivity checks were performed to assess how alternative assumptions might influence strategic recommendations. This mixed-methods approach ensures that the insights presented are both evidence-based and practically grounded.

A strategic synthesis that underscores why modular architectures, workforce investment, and resilient procurement are essential to realize the full potential of NGS informatics

In conclusion, the informatics layer of next-generation sequencing has transitioned from an operational expense to a strategic asset that shapes scientific outcomes, clinical pathways, and commercial competitiveness. Technological advances, including improved algorithms, cloud-native architectures, and richer sequencing modalities, are expanding what is possible, but they also increase complexity in governance, validation, and workforce requirements. The imposition of tariffs and evolving regional dynamics further complicate procurement and deployment decisions, underscoring the need for flexible sourcing models and robust scenario planning.

Success in this environment will depend on the ability to marry technical excellence with pragmatic operational design: prioritize modular, standards-based architectures that can evolve with new analytical techniques; build partnerships that supplement internal capabilities while preserving control of core intellectual property; and invest in workforce development to bridge the gap between domain expertise and software engineering. Organizations that adopt these principles will be better positioned to extract value from sequencing data, accelerate translational research, and deliver clinically actionable insights with confidence.

Ultimately, the path forward is not a single blueprint but a set of strategic choices that reflect each organization's risk tolerance, regulatory obligations, and mission. By understanding the segmentation dynamics, regional considerations, and vendor landscape, leaders can make informed decisions that balance innovation with reliability and cost-effectiveness.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. NGS Informatics Market, by Component

  • 8.1. Services
    • 8.1.1. Custom Services
    • 8.1.2. Subscription Services
  • 8.2. Software Tools
    • 8.2.1. Data Management Tools
    • 8.2.2. Sequencing Data Analysis Tools
    • 8.2.3. Visualization Tools

9. NGS Informatics Market, by Technology

  • 9.1. Data Analysis
    • 9.1.1. Alignment And Mapping
    • 9.1.2. Annotation And Interpretation
    • 9.1.3. Variant Calling
  • 9.2. Data Management
    • 9.2.1. Electronic Data Capture Systems
    • 9.2.2. Laboratory Information Management Systems
  • 9.3. Data Storage
    • 9.3.1. Cloud Storage
    • 9.3.2. On-Premise Storage

10. NGS Informatics Market, by Deployment Mode

  • 10.1. Cloud
    • 10.1.1. Private Cloud
    • 10.1.2. Public Cloud
  • 10.2. On-Premise

11. NGS Informatics Market, by Workflow Type

  • 11.1. Primary Analysis
    • 11.1.1. Base Calling
    • 11.1.2. Image Processing
  • 11.2. Secondary Analysis
    • 11.2.1. Alignment
    • 11.2.2. Quality Control
    • 11.2.3. Variant Calling
  • 11.3. Tertiary Analysis
    • 11.3.1. Data Mining
    • 11.3.2. Reporting And Visualization

12. NGS Informatics Market, by Application

  • 12.1. Cancer Research
    • 12.1.1. Hematologic Cancer
    • 12.1.2. Solid Tumor
  • 12.2. Genetic Disorder Research
  • 12.3. Infectious Disease
    • 12.3.1. Bacterial Genomics
    • 12.3.2. Viral Genomics
  • 12.4. Reproductive Health
    • 12.4.1. Paternity Testing
    • 12.4.2. Prenatal Screening

13. NGS Informatics Market, by End User

  • 13.1. Academic And Research Institutes
    • 13.1.1. Private Research Institutes
    • 13.1.2. Public Universities
  • 13.2. Contract Research Organizations
  • 13.3. Healthcare Providers
    • 13.3.1. Diagnostic Laboratories
    • 13.3.2. Hospitals
  • 13.4. Pharmaceutical And Biotechnology Companies
    • 13.4.1. Large Pharmaceutical Companies
    • 13.4.2. Small Biotechnology Companies

14. NGS Informatics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. NGS Informatics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. NGS Informatics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States NGS Informatics Market

18. China NGS Informatics Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Agilent Technologies Inc.
  • 19.6. Azenta Life Sciences
  • 19.7. BGI Genomics Co., Ltd.
  • 19.8. Bio-Rad Laboratories, Inc.
  • 19.9. Dassault Systemes
  • 19.10. Dnanexus Inc.
  • 19.11. DNASTAR Inc.
  • 19.12. Eagle Genomics Ltd.
  • 19.13. F. Hoffmann-La Roche Ltd.
  • 19.14. Fabric Genomics Inc.
  • 19.15. Genedata AG
  • 19.16. IBM Corporation
  • 19.17. Illumina, Inc.
  • 19.18. Partek Incorporated
  • 19.19. PerkinElmer, Inc
  • 19.20. PerkinElmer, Inc.
  • 19.21. PierianDx, Inc.
  • 19.22. Qiagen N.V.
  • 19.23. Real Time Genomics Inc.
  • 19.24. Roche Diagnostics International AG
  • 19.25. Sapio Sciences
  • 19.26. SoftGenetics, LLC
  • 19.27. Thermo Fischer Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NGS INFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NGS INFORMATICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NGS INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NGS INFORMATICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NGS INFORMATICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NGS INFORMATICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES NGS INFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA NGS INFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NGS INFORMATICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NGS INFORMATICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NGS INFORMATICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NGS INFORMATICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NGS INFORMATICS MARKET SIZE, BY CUSTOM SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NGS INFORMATICS MARKET SIZE, BY CUSTOM SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NGS INFORMATICS MARKET SIZE, BY CUSTOM SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NGS INFORMATICS MARKET SIZE, BY SUBSCRIPTION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NGS INFORMATICS MARKET SIZE, BY SUBSCRIPTION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NGS INFORMATICS MARKET SIZE, BY SUBSCRIPTION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NGS INFORMATICS MARKET SIZE, BY SEQUENCING DATA ANALYSIS TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NGS INFORMATICS MARKET SIZE, BY SEQUENCING DATA ANALYSIS TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NGS INFORMATICS MARKET SIZE, BY SEQUENCING DATA ANALYSIS TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NGS INFORMATICS MARKET SIZE, BY VISUALIZATION TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NGS INFORMATICS MARKET SIZE, BY VISUALIZATION TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NGS INFORMATICS MARKET SIZE, BY VISUALIZATION TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT AND MAPPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT AND MAPPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT AND MAPPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NGS INFORMATICS MARKET SIZE, BY ANNOTATION AND INTERPRETATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NGS INFORMATICS MARKET SIZE, BY ANNOTATION AND INTERPRETATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NGS INFORMATICS MARKET SIZE, BY ANNOTATION AND INTERPRETATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NGS INFORMATICS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NGS INFORMATICS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NGS INFORMATICS MARKET SIZE, BY ELECTRONIC DATA CAPTURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NGS INFORMATICS MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NGS INFORMATICS MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NGS INFORMATICS MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NGS INFORMATICS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NGS INFORMATICS MARKET SIZE, BY BASE CALLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NGS INFORMATICS MARKET SIZE, BY BASE CALLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NGS INFORMATICS MARKET SIZE, BY BASE CALLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NGS INFORMATICS MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NGS INFORMATICS MARKET SIZE, BY IMAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NGS INFORMATICS MARKET SIZE, BY IMAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NGS INFORMATICS MARKET SIZE, BY ALIGNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NGS INFORMATICS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NGS INFORMATICS MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NGS INFORMATICS MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NGS INFORMATICS MARKET SIZE, BY VARIANT CALLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NGS INFORMATICS MARKET SIZE, BY DATA MINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPORTING AND VISUALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPORTING AND VISUALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPORTING AND VISUALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEMATOLOGIC CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEMATOLOGIC CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEMATOLOGIC CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOLID TUMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOLID TUMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NGS INFORMATICS MARKET SIZE, BY SOLID TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NGS INFORMATICS MARKET SIZE, BY GENETIC DISORDER RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NGS INFORMATICS MARKET SIZE, BY GENETIC DISORDER RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL NGS INFORMATICS MARKET SIZE, BY GENETIC DISORDER RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NGS INFORMATICS MARKET SIZE, BY BACTERIAL GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL NGS INFORMATICS MARKET SIZE, BY BACTERIAL GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NGS INFORMATICS MARKET SIZE, BY BACTERIAL GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NGS INFORMATICS MARKET SIZE, BY VIRAL GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NGS INFORMATICS MARKET SIZE, BY VIRAL GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NGS INFORMATICS MARKET SIZE, BY VIRAL GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL NGS INFORMATICS MARKET SIZE, BY PATERNITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NGS INFORMATICS MARKET SIZE, BY PATERNITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL NGS INFORMATICS MARKET SIZE, BY PATERNITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRENATAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRENATAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL NGS INFORMATICS MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL NGS INFORMATICS MARKET SIZE, BY PUBLIC UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL NGS INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL NGS INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL NGS INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL NGS INFORMATICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL NGS INFORMATICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL NGS INFORMATICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL NGS INFORMATICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL NGS INFORMATICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL NGS INFORMATICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL NGS INFORMATICS MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL NGS INFORMATICS MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL NGS INFORMATICS MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL NGS INFORMATICS MARKET SIZE, BY SMALL BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL NGS INFORMATICS MARKET SIZE, BY SMALL BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL NGS INFORMATICS MARKET SIZE, BY SMALL BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL NGS INFORMATICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS NGS INFORMATICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPE NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPE NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 290. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 304. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 308. MIDDLE EAST NGS INFORMATICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 309. AFRICA NGS INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. AFRICA NGS INFORMATICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 311. AFRICA NGS INFORMATICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 312. AFRICA NGS INFORMATICS MARKET SIZE, BY SOFTWARE TOOLS, 2018-2032 (USD MILLION)
  • TABLE 313. AFRICA NGS INFORMATICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 314. AFRICA NGS INFORMATICS MARKET SIZE, BY DATA ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 315. AFRICA NGS INFORMATICS MARKET SIZE, BY DATA MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 316. AFRICA NGS INFORMATICS MARKET SIZE, BY DATA STORAGE, 2018-2032 (USD MILLION)
  • TABLE 317. AFRICA NGS INFORMATICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 318. AFRICA NGS INFORMATICS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 319. AFRICA NGS INFORMATICS MARKET SIZE, BY WORKFLOW TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. AFRICA NGS INFORMATICS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 321. AFRICA NGS INFORMATICS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 322. AFRICA NGS INFORMATICS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 323. AFRICA NGS INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. AFRICA NGS INFORMATICS MARKET SIZE, BY CANCER RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 325. AFRICA NGS INFORMATICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 326. AFRICA NGS INFORMATICS MARKET SIZE, BY REPRODUCTIVE HEALTH,